You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Light chain Amyloidosis

Showing 1 - 25 of 6,533
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Light Chain (AL) Amyloidosis, CCND1 Translocation, Venetoclax Trial (Venetoclax, Dexamethasone Oral)

Not yet recruiting
  • Light Chain (AL) Amyloidosis
  • +2 more
  • (no location specified)
Aug 16, 2023

Light Chain Amyloidosis Trial (FKC288)

Not yet recruiting
  • Light Chain Amyloidosis
  • (no location specified)
Jul 30, 2023

Relapsed/Refractory Multiple Myeloma, Amyloid Light-chain Amyloidosis Trial (SAR445514)

Not yet recruiting
  • Relapsed/Refractory Multiple Myeloma
  • Amyloid Light-chain Amyloidosis
  • (no location specified)
Apr 20, 2023

Amyloidosis, Light Chain (AL) Amyloidosis Trial (Bendamustine Hydrochloride, Isatuximab)

Withdrawn
  • Amyloidosis
  • Light Chain (AL) Amyloidosis
  • (no location specified)
Dec 29, 2022

AL Amyloidosis Trial in Scottsdale, Jacksonville, Rochester (procedure, biological, other)

Not yet recruiting
  • AL Amyloidosis
  • Bone Marrow Biopsy
  • +4 more
  • Scottsdale, Arizona
  • +2 more
Jun 2, 2023

AL Amyloidosis, Light Chain (AL) Amyloidosis, Systemic Light Chain Disease Trial in San Francisco (Venetoclax, Dexamethasone,

Not yet recruiting
  • AL Amyloidosis
  • +2 more
  • San Francisco, California
    University of California, San Francisco
Aug 16, 2022

Amyloid, Amyloidosis, AL Amyloidosis Trial in New York (Selinexor, Dexamethasone)

Suspended
  • Amyloid
  • +2 more
  • New York, New York
    Weill Cornell Medicine - Multiple Myeloma Center
May 17, 2022

Immunoglobulin Light-chain Amyloidosis Trial (Live Combined Bacillus Subtilis and Enterococcus Faecium Enteric-coated Capsules

Not yet recruiting
  • Immunoglobulin Light-chain Amyloidosis
  • Live Combined Bacillus Subtilis and Enterococcus Faecium Enteric-coated Capsules combined with Bortezomib+Dexamethasone/Bortezomib+Dexamethasone+Daratumumab/single Daratumumab
  • Bortezomib+Dexamethasone/Bortezomib+Dexamethasone+Daratumumab/single Daratumumab
  • (no location specified)
Mar 18, 2023

Light Chain Deposition Disease, Primary Systemic Amyloidosis Trial in Canada, United States (pomalidomide, bortezomib,

Active, not recruiting
  • Light Chain Deposition Disease
  • Primary Systemic Amyloidosis
  • Denver, Colorado
  • +4 more
Jan 20, 2023

Amyloid, Amyloid Cardiomyopathy Trial in Pisa (18F-florbetaben PET/CT)

Recruiting
  • Amyloid
  • Amyloid Cardiomyopathy
  • 18F-florbetaben PET/CT
  • Pisa, Italy
    Fondazione Toscana Gabriele Monasterio
Sep 16, 2023

Light Chain (AL) Amyloidosis Trial (STI-6129)

Not yet recruiting
  • Light Chain (AL) Amyloidosis
  • STI-6129
  • (no location specified)
Jan 11, 2023

Left and Right Ventricular Global Strain After Chemotherapy in

Recruiting
  • Amyloid Cardiomyopathy
  • +2 more
  • Left and Right Ventricular Global Strain Imaging
  • Istanbul, Fatih, Turkey
    Istanbul University-Cerrahpasa
Aug 11, 2022

Amyloidosis; Systemic Trial in Beijing (Daratumumab, Bortezomib, Dexamethasone)

Active, not recruiting
  • Amyloidosis; Systemic
  • Beijing, China
    Peking Union Medical College Hospital
May 9, 2022

Left Atrial Strain and Supraventricular Arrhythmia Burden in

Recruiting
  • Supraventricular Arrhythmia
  • +3 more
  • Left Atrial Strain Imaging
  • Electrocardiography
  • Istanbul, Turkey
    Istanbul University-Cerrahpasa
Aug 10, 2022

Clinical Study for AL-CM

Recruiting
  • Immunoglobulin Light Amyloidosis Cardiomyopathy
  • current treatment of AL-CM
  • Hangzhou, Zhejiang, China
    2nd Affiliated Hospital, School of Medicine, Zhejiang University
Jan 29, 2023

AL Amyloidosis Trial in New York (Venetoclax Oral Tablet, 200 mg, FISH assay, Venetoclax Oral Tablet, 400 mg)

Not yet recruiting
  • AL Amyloidosis
  • Venetoclax Oral Tablet, 200 mg
  • +9 more
  • New York, New York
    New York Presbyterian Hospital/Columbia University Irving Medica
Jul 11, 2022

Amyloidosis, Primary, Cardiomyopathy Trial in Boston (F-18 florbetapir/C-11 acetate PET, MRI, N-13 ammonia PET)

Recruiting
  • Amyloidosis, Primary
  • Cardiomyopathy
  • F-18 florbetapir/C-11 acetate PET
  • +2 more
  • Boston, Massachusetts
    Brigham and Womens' Hospital
Oct 23, 2022

Light Chain (AL) Amyloidosis Trial in Sacramento (NXC-201 CAR-T)

Not yet recruiting
  • Light Chain (AL) Amyloidosis
  • NXC-201 CAR-T
  • Sacramento, California
    University of California Davis Medical Center
Oct 19, 2023

Primary Systemic Amyloidosis, Light Chain Deposition Disease Trial in United States (drug, genetic, other, procedure)

Active, not recruiting
Has Results
  • Primary Systemic Amyloidosis
  • Light Chain Deposition Disease
  • Denver, Colorado
  • +6 more
Aug 24, 2022

Light Chain (AL) Amyloidosis Trial in New York (STI-6129)

Recruiting
  • Light Chain (AL) Amyloidosis
  • STI-6129
  • Duarte, California
  • +3 more
Jan 12, 2023

Amyloidosis, AL Amyloidosis Trial in Worldwide (ZN-d5)

Recruiting
  • Amyloidosis
  • AL Amyloidosis
  • Denver, Colorado
  • +1 more
Jan 18, 2022

AL Amyloidosis Trial in Palo Alto, Detroit, Cleveland (CAEL-101, SoC: cyclophosphamide, bortezomib, and Dexamethasone (CyBorD),

Active, not recruiting
  • AL Amyloidosis
  • Palo Alto, California
  • +2 more
Dec 6, 2022

AL Amyloidosis Trial in Catanzaro, Pavia, Rome (daratumumab and pomalidomide)

Recruiting
  • AL Amyloidosis
  • daratumumab and pomalidomide
  • Catanzaro, Italy
  • +2 more
Aug 3, 2022

AL Amyloidosis Trial in Pavia

Recruiting
  • AL Amyloidosis
    • Pavia, Italy
      Fondazione IRCCS Policlinico San Matteo
    May 4, 2022

    AL Amyloidosis Trial in Beijing

    Recruiting
    • AL Amyloidosis
      • Beijing, China
        Peking Union Medical College Hospital
      Apr 20, 2022